发明名称 |
COMPOSITIONS AND METHODS FOR OSTEOGENIC GENE THERAPY |
摘要 |
The present disclosure provides compositions and methods for increasing bone growth and/or enhancing wound healing, for example, fracture repair. The disclosure provides recombinant nucleic acids useful for promoting bone growth. For example, the disclosure provides recombinant nucleic acids that encode a fibroblast growth factor-2 (FGF-2) analog. The disclosure also provides vectors and cells incorporating these nucleic acids, as well as FGF-2 analogs encode by them. The disclosure also provides a mouse system of bone marrow transplantation and methods for producing as well as methods for using the system. Methods for inducing division and/or inducing differentiation of a hematopoietic stem cell are also provided, as are methods for enhancing bone growth and/or wound repair (for example, fracture repair). |
申请公布号 |
US2014256917(A1) |
申请公布日期 |
2014.09.11 |
申请号 |
US201414287991 |
申请日期 |
2014.05.27 |
申请人 |
The United States Government as represented by the Department of Veterans Affairs ;Loma Linda University |
发明人 |
Lau Kin-Hing William;Hall Susan L.;Chen Shin-Tai;Mohan Subburaman;Baylink David J. |
分类号 |
C07K14/50;C12N15/11 |
主分类号 |
C07K14/50 |
代理机构 |
|
代理人 |
|
主权项 |
1. A recombinant nucleic acid encoding a modified fibroblast growth factor-2 (FGF-2) analog, wherein the nucleic acid comprises in a 5′ to 3′ direction:
a polynucleotide sequence that encodes a BMP2/4 hybrid secretion signal sequence; and a polynucleotide sequence that encodes a mature human FGF-2 polypeptide, wherein the mature human FGF-2 polypeptide comprises at least one of: a mutation that results in the substitution of a glycosylatable amino acid for a cysteine in amino acid position 70 (C2) of FGF-2, and a mutation that results in the substitution of a glycosylatable amino acid for a cysteine in amino acid position 88 (C3) of FGF-2. |
地址 |
Baltimore MD US |